Theratechnologies inc.
TSX : TH

Theratechnologies inc.

January 29, 2007 14:24 ET

Theratechnologies' CEO to Address Vancouver Board of Trade

MONTREAL, QUEBEC--(CCNMatthews - Jan. 29, 2007) - Theratechnologies (TSX:TH) announced today that Yves Rosconi, President and Chief Executive Officer of the Company, will be speaking at a luncheon meeting of the Vancouver Board of Trade on Wednesday, January 31. Mr. Rosconi's address will be entitled "A prescription for sustainability in Canadian Biotech". The event is part of the Board of Trade's Distinguished Speaker series.

About Theratechnologies

Theratechnologies (TSX:TH) is a Canadian biopharmaceutical company that discovers or acquires novel therapeutic products for development and commercialization. These products target unmet medical needs in commercially attractive specialty markets. The most advanced program is in Phase 3 clinical development in HIV-associated lipodystrophy. The Company also has other promising projects at various stages of development.

Contact Information

  • Theratechnologies Inc.
    Patricia Delaney Lussier
    Communications
    514-336-4804, Ext. 234
    www.theratech.com